Alzheimer Disease Clinical Trials in London
9 recruitingLondon, United Kingdom
Showing 1–9 of 9 trials
Recruiting
Phase 3
A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
Alzheimer DiseaseAgitation
Bristol-Myers Squibb600 enrolled241 locationsNCT06937229
Recruiting
Phase 1
A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease
Alzheimer Disease
Eli Lilly and Company48 enrolled10 locationsNCT06297590
Recruiting
Phase 3
A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 5)
DementiaBrain DiseasesCentral Nervous System Diseases+6 more
Eli Lilly and Company1,500 enrolled141 locationsNCT05508789
Recruiting
Phase 3
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-2)
Alzheimer Disease
Bristol-Myers Squibb352 enrolled140 locationsNCT07011745
Recruiting
Phase 1
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DNL628 in Participants With Early Alzheimer's Disease
Alzheimer Disease, Early Onset
Denali Therapeutics Inc.68 enrolled1 locationNCT07328451
Recruiting
Longitudinal Early-onset Alzheimer's Disease Study Protocol
Early-Onset Alzheimer DiseaseAlzheimer DiseaseMild Cognitive Impairment
Indiana University850 enrolled23 locationsNCT03507257
Recruiting
Phase 1
A Trial Evaluating the Effect of NIO752 on Tau Synthesis Measured by a Process Known as SILK
Alzheimer DiseaseAutosomal Dominant Alzheimer Disease Due to Mutation of Presenilin 1 (Disorder)Autosomal Dominant Alzheimer Disease Due to Mutation of Presenilin 2 (Disorder)+1 more
University College, London10 enrolled2 locationsNCT06372821
Recruiting
Phase 1
A Study to Assess THN391 in Subjects With Alzheimer's Disease
Alzheimer Disease, Early Onset
Therini Bio, Inc.15 enrolled4 locationsNCT06814730
Recruiting
Multidisciplinary Expert System for the Assessment & Management of Complex Brain Disorders
DementiaEpilepsyHealthy+3 more
Neurological Institute of Athens350 enrolled4 locationsNCT05171725